01P — Medpace Holdings Balance Sheet
0.000.00%
- €7.55bn
- €7.16bn
- $2.11bn
- 99
- 22
- 46
- 57
Annual balance sheet for Medpace Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 278 | 461 | 28.3 | 245 | 669 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 161 | 186 | 253 | 298 | 296 |
Prepaid Expenses | |||||
Total Current Assets | 474 | 691 | 334 | 594 | 1,029 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 199 | 223 | 249 | 265 | 252 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 1,391 | 1,660 | 1,352 | 1,657 | 2,101 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 440 | 557 | 803 | 925 | 1,105 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 585 | 707 | 966 | 1,098 | 1,275 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 806 | 953 | 386 | 559 | 826 |
Total Liabilities & Shareholders' Equity | 1,391 | 1,660 | 1,352 | 1,657 | 2,101 |
Total Common Shares Outstanding |